KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Net Margin (2018 - 2025)

Historic Net Margin for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to 5.14%.

  • BioNTech SE's Net Margin fell 44400.0% to 5.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.8%, marking a year-over-year increase of 59000.0%. This contributed to the annual value of 25.08% for FY2024, which is 494400.0% down from last year.
  • BioNTech SE's Net Margin amounted to 5.14% in Q3 2025, which was down 44400.0% from 148.24% recorded in Q2 2025.
  • BioNTech SE's Net Margin's 5-year high stood at 99.42% during Q1 2022, with a 5-year trough of 624.55% in Q2 2024.
  • Moreover, its 5-year median value for Net Margin was 28.82% (2024), whereas its average is 29.71%.
  • As far as peak fluctuations go, BioNTech SE's Net Margin plummeted by -5110200bps in 2024, and later soared by 4763200bps in 2025.
  • BioNTech SE's Net Margin (Quarter) stood at 0.0% in 2021, then skyrocketed by 93067603bps to 53.26% in 2022, then crashed by -42bps to 30.96% in 2023, then fell by -7bps to 28.82% in 2024, then crashed by -82bps to 5.14% in 2025.
  • Its Net Margin stands at 5.14% for Q3 2025, versus 148.24% for Q2 2025 and 227.46% for Q1 2025.